All stock lists
Olin Corporation (New York Stock Exchange:OLN)
US · Delayed Price · Currency is USD
Basic Materials · Chemicals
Russell 2000 since Dec 2023
17.60+1.55 (+9.66%)
Market cap
$2.01B
Insider Score
Health Score
Analyst consensus
Listed since
Dec 30, 1987
Website
Insider Score
––Not scored
OLN Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Fair
From OLN’s reported statements · Q3 2026 (trailing 12 months)
Profitability9 / 20
Loses money on what it sells.
- Revenue
- $6.74B
- Net income
- -$167.6M
- Net margin
- -2.5%
Leverage0 / 20
Heavily indebted for what it earns.
- Total debt
- $3.40B
- Cash
- $214.8M
- Net debt / EBITDA
- 7.29x
Liquidity13 / 20
Covers near-term obligations, without much room.
- Current assets
- $2.20B
- Current liabilities
- $1.51B
- Current ratio
- 1.45
Cash generation13 / 20
Roughly cash-neutral.
- Operating cash flow
- $321.2M
- Free cash flow
- $151.8M
- FCF margin
- 2.3%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 114.0M
- Share growth (1y)
- -0.8%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
OLN Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | 1.75 B | 1.74 B | 1.58 B | 1.67 B | 1.71 B | 1.76 B |
| Revenue Growth (YoY) | 2.01 % | -0.93 % | -3.72 % | -0.37 % | 7.78 % | 6.95 % |
| Cost of Revenue | 1.57 B | 1.57 B | 1.51 B | 1.63 B | 1.53 B | 1.62 B |
| Gross Profit | 172.70 M | 170.20 M | 75.80 M | 31.30 M | 183.40 M | 138.10 M |
| SG&A Expense | 98.40 M | 102.70 M | 145.00 M | 94.00 M | 1.70 B | 90.30 M |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 113.50 M | 123.70 M | 145.00 M | 94.00 M | 183.00 M | 102.80 M |
| Operating Income | 59.20 M | 46.50 M | -69.20 M | -62.70 M | 400.00 K | 35.30 M |
| Pretax Income | 17.10 M | 3.80 M | -118.30 M | -122.90 M | 45.90 M | -6.80 M |
| Tax Provision | 2.70 M | 17.10 M | -35.30 M | -37.40 M | 2.20 M | -4.00 M |
| Net Income | 14.40 M | -13.30 M | -83.00 M | -85.70 M | 43.00 M | -1.30 M |
| EPS (Basic) | 0.13 | -0.12 | -0.73 | -0.75 | 0.37 | -0.01 |
| EPS (Diluted) | 0.13 | -0.12 | -0.73 | -0.75 | 0.37 | -0.01 |
| Shares Outstanding | 114.00 M | 113.90 M | 113.80 M | 113.90 M | 114.90 M | 115.10 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.